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A B S T R A C T
The tumor suppressor p16INK4A induces cell cycle arrest and senescence in response to oncogenic transformation
and is therefore frequently lost in cancer. p16INK4A is also known to accumulate under conditions of oxidative
stress. Thus, we hypothesized it could potentially be regulated by reversible oxidation of cysteines (redox sig-
naling). Here we report that oxidation of the single cysteine in p16INK4A in human cells occurs under relatively
mild oxidizing conditions and leads to disulfide-dependent dimerization. p16INK4A is an all α-helical protein, but
we find that upon cysteine-dependent dimerization, p16INK4A undergoes a dramatic structural rearrangement
and forms aggregates that have the typical features of amyloid fibrils, including binding of diagnostic dyes,
presence of cross-β sheet structure, and typical dimensions found in electron microscopy. p16INK4A amyloid
formation abolishes its function as a Cyclin Dependent Kinase 4/6 inhibitor. Collectively, these observations
mechanistically link the cellular redox state to the inactivation of p16INK4A through the formation of amyloid
fibrils.
1. Introduction
The CDKN2A gene-product p16INK4A is an important cell-cycle
regulator and acts as a tumor suppressor. It inhibits the D-type cyclin-
dependent kinases CDK4 and CDK6 and hence prevents the downstream
phosphorylation of the retinoblastoma (Rb) pocket protein [1]. This
prevents release of E2 promoter binding factor 1 (E2F1), which is
otherwise required for the transcriptional regulation of proteins that
control controlentry into S-phase of the cell cycle [2]. Accumulation of
p16INK4A is observed upon exposure of cells to several stressors such as
oxidative stress and is one of the earliest markers of oncogenic trans-
formation [3]. The loss of p16INK4A function, or loss of Rb downstream
of CDK4/6, are some of the most frequently observed mutations in
tumors [4]. Additionally, p16INK4A plays an important role in aging, as
clearance of p16INK4A-expressing senescent cells has been shown to
prolong lifespan in mice [5,6].
The molecular basis of p16INK4A-mediated CDK4/6 inhibition is well
established. p16INK4A is a small, globular all-α-helical protein, that
tightly binds into one side of the catalytic cleft of the CDK4/6 kinases. It
efficiently distorts the cyclin D binding site, thereby blocking formation
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of the active CDK4/6-cyclin D complex, and preventing Rb phosphor-
ylation [7,8]. Of particular relevance for this study, the single cysteine
residue (C72) present in p16INK4A is located on its surface and points
away from the CDK4/6 kinase in the bound state; the residue is fully
solvent accessible.
Reversible cysteine oxidation is the lynchpin in redox signaling, a
form of signal transduction that is regulated by the cellular redox state.
A more oxidizing cellular redox state, either due to elevated reactive
oxygen species or a lack of reducing power, leads to oxidative mod-
ification of specific cysteine-thiols to form reversible disulfide (S–S)
bridges. These oxidative modifications can lead to structural re-
arrangements and can both negatively and positively regulate protein
function (for a review see Ref. [9]).
A number of observations spurred us to hypothesize that oxidation
of p16INK4A C72 could play a role in the regulation of p16INK4A activity
at the molecular level. Firstly, several studies have implicated a role for
increased ROS in the oncogene-induced accumulation of p16INK4A [10],
but cysteine oxidation as the underlying mechanism has thus far not
been considered nor excluded. Secondly, we identified p16INK4A as
prone to cysteine oxidation in a large mass-spectrometry based screen
for redox sensitive proteins [11]. Here, we provide evidence that
p16INK4A itself is indeed sensitive to cysteine oxidation. We find that
p16INK4A is readily oxidized both in vitro and in cultured human cells to
form a disulfide-dependent homodimer, and the oxidizing conditions
required are well within the physiological range. Surprisingly, dis-
ulfide-dependent dimerization of p16INK4A subsequently leads to the
rapid formation of β-sheet amyloid fibril structures, a state that has not
been previously described for p16INK4A. This transition subsequently
leads to loss of CDK4/6 inhibitory capacity. Redox signaling-induced
reversible disulfides have not previously been shown to induce β-sheet
amyloid fibrils in other proteins and hence adds to the repertoire of
redox dependent protein regulation.
2. Materials & methods
2.1. Cell lines, plasmids, antibodies and compounds
Cells (HEK293T, COLO829) were cultured in DMEM low glucose
supplemented with FCS (10%), L-glutamine (2 mM) and Penicillin-
Streptomycin (100 Units-0.1 mg per ml medium) (all from Lonza). Cells
were transfected using PEI (Sigma Aldrich) or X-tremeGENE 9 (Roche)
according to manufacturer's instruction.
The vector containing the truncated form (Δ1–8) of wild type
p16INK4A was a gift from R. Medema [12]. The cysteine mutant of
p16INK4A was created by site-directed pcr mutagenesis. mCherry-
(backbone pLV-CMV-bc) and FLAG-His-tagged (backbone pCDNA3)
and doxycycline-inducible (backbone pINDUCER20, Addgene #44012)
p16INK4A constructs were created using Gateway technology (Life
Technologies). COLO-829 melanoma cells stably expressing doxycyline-
inducible constructs were transduced with lentivirus containing pIN-
DUCER20-p16INK4A or -p16INK4AC72A. Cells were selected for stable
transduction using geneticin and p16INK4A expression was confirmed by
qPCR and western blotting. Subsequently, cells were transduced with
lentivirus containing the FUCCI cell cycle probes mAG-hGeminin(1/
110)/pCSII-EF (#RDB15268) and Fucci-G1 phase probe mKO2-
hCdt1(30/120)/pCSII-EF (#RDB15267) (RIKEN BioResource Center),
which were a kind gift from A. Miyawaki [13]. Cells were selected for
stable transduction using zeocin and made monoclonal by limiting di-
lution.
The following antibodies were used in this study: FLAG (M2 F3165
Sigma Aldrich), p16INK4A (10883 Proteintech), p16INK4A (ab16123
Abcam), CDK4 (C-22 Santa Cruz), CDK6 (C-21 Santa Cruz), tubulin
(CP06 Merck Millipore), Phospho-Rb Ser807/811 (9308 Cell Signaling).
Solutions/compounds not mentioned elsewhere: 35% hydrogen
peroxide (Merck).
2.2. Co-immunoprecipitation, SDS-PAGE and western blotting
Immuno-precipitation of endogenous p16 was done with rabbit anti-
p16INK4A (10883 Proteintech) using three 10 cm dishes of HEK293T
cells per sample. Transfection was performed two days prior to sample
preparation. Cells were scraped in 100mM N-ethyl-maleimide in PBS
(37 °C) to prevent post-lysis oxidation and collected by centrifugation at
1200 rpm for 3 min. Cells were lysed in a standard lysis buffer con-
taining 50 mM Tris pH 7.5, 1% Triton X-100, 1.5 mM MgCl2, 5 mM
EDTA, 100mM NaCl supplemented with Aprotinin, Leupeptin and NaF.
100 mM iodoacetamide was added to prevent post-lysis oxidation of
cysteines. The cell lysates were subsequently centrifuged at 14000 rpm
for 10 min. 50 μl of the supernatant was kept as input. For im-
munoprecipitation of endogenous p16INK4A the pellet was resuspended
in lysis buffer, sonicated and supplemented with 125 U of benzonase
and incubated for 1 h at 37°. The remaining supernatant (and where
indicated also the resolubilized pellet) was used for immunoprecipita-
tion with the indicated antibody coupled to protein A-Agarose (Roche)
or in case of transfected FLAG-tagged constructs with anti-FLAG M2
Affinity gel (Sigma Aldrich). After 2 h of incubation, beads were washed
3 times with standard lysis buffer supplemented with extra NaCl (1 M
final concentration). After washing, samples were split into two parts,
and sample buffer with or without a reducing agent (β-mercap-
toethanol) was added. Samples were boiled for 5 min and separated on
a 15% polyacrylamide gel. For Western Blotting, proteins were trans-
ferred to immobilon-FL membranes. For diagonal electrophoresis, non-
reducing samples were separated on a 15% polyacrylamide gel, after
which the entire protein containing lane was excised, reduced, and
separated on a new 15% polyacrylamide gel. For visualization of di-
agonal electrophoresis proteins were stained by SimplyBlue.
2.3. Filter trap assay
HEK293T cells were transfected with FLAG-p16INK4A, FLAG-
p16INK4AC72A or GFP as a control. After two days, cells were scraped in
100 mM N-ethyl-maleimide in PBS (37 °C) to prevent post-lysis oxida-
tion and collected by centrifugation at 1200 rpm for 3 min. Lysis buffer
(50mM Tris pH 7.5, 1% v/v Triton X-100, 1.5 mM MgCl2, 5 mM EDTA,
100 mM NaCl, Protease inhibitors (Aprotinin + Leupeptin), NaF,
100 mM iodoacetamide) added for 10 min followed by centrifugation
for 15 min at 14000 rpm in an Eppendorf microfuge. The pellet was
resuspended in benzonase buffer (50 mM Tris-HCL pH 8.0, 1 mM
MgCl2) and 125 U of benzonase was added followed by incubation for
1 h at 37°. The reaction was stopped by adding 2x termination buffer
(40 mM EDTA, 0.2% SDS, with or without 10 mM DTT). Protein con-
tent was measured using the BCA kit and 50 μg of protein per sample
were loaded on a Bio Dot apparatus (Biorad) equipped with a 0.2 μm
pore size nitrocellulose membrane soaked in buffer B (10 mM Tris-HCL
pH 8.0, 150 mM NaCl, 2% SDS) on top of two Whatmann paper filters
soaked in Buffer A (10 mM Tris-HCL pH 8.0, 150 mM NaCl, 1% SDS),
after pre-washing the membrane with 100 μl of buffer A. Samples were
pulled through the membrane using vacuum, followed by washing
thrice with 100 μl of buffer A. The nitrocellulose membrane was further
processed as for Western Blotting to detect trapped p16INK4A.
2.4. Kinase assay
The kinase assays in this study were performed with im-
munoprecipitated FLAG-p16INK4A or FLAG-p16INK4AC72A and the at-
tached binding-partners. Beads were washed three times with standard
lysis buffer followed by two washes with kinase buffer containing 25
mM Tris pH 7.5 and 10 mM MgCl2. The beads were subsequently in-
cubated for 30 min at 30 °C in 20 μl kinase buffer supplemented with 1
mM DTT, 1 μg human GST-Rb (48–378 Sigma Aldrich) as substrate and
0.2 mM ATP. Directly after the assay beads were boiled for 5 min in
reducing sample buffer and loaded on a 15% polyacrylamide gel
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followed by Western Blotting.
2.5. RNA extraction, cDNA synthesis and qPCR
Doxycylcine-inducible p16INK4A expressing Colo-829 cells were
plated, and 24 h before harvesting doxycline was added to induce ex-
pression of p16INK4A or p16INK4AC72A. Cells were treated as indicated.
Cells were washed once with PBS and collected in RLT buffer. RNA was
extracted using the RNeasy kit (Qiagen) according to the manufacturer's
instructions. 1 μg RNA was used as input for cDNA synthesis using the
iScript cDNA synthesis kit (Biorad). qPCR was performed with FastStart
SYBR Green Master mix (Roche) using the CFX96 Touch Real-Time PCR
Detection System. Relative gene expression was calculated using the
ΔΔCt method [14] by normalization to HNRNPA1. Statistics were done
with Graphpad Prism 8. Primer sequences: p16INK4A forward (5′-CAA
CGCACCGAATAGTTACG-3′), p16INK4A reverse (5′-ACCAGCGTGTCCAG
GAAG-3′), CCNE2 forward (5′-GGGGGATCAGTCCTTGCATT-3′), CCNE2
reverse (5′-TCCCCAGCTTAAATCAGGCA-3′), HNRNPA1 forward (
5′-GGAAGCTACAGGTTACAACA-3′), HNRNPA1 reverse (5′-AGTCACA
AATACAGTCCTCG-3′).
2.6. Protein expression and purification
An Escherichia coli codon-optimized gene of Homo sapiens p16INK4A
(UniProt ID: P42771) was cloned into a modified version of pETM-11
that includes a 6xHis, a protein A tag and a tobacco etch virus (TEV)
protease cleavage site, leaving an additional glycine residue at the N-
terminal cleavage site. For a glycerol stock solution, competent E. coli
BL21 (DE3) cells were transformed with the p16INK4A harboring gene
and inoculated in minimal medium in the presence of kanamycin (50
μg/l). After overnight incubation at 37 °C the cell suspension was mixed
with glycerol to 50% (v/v) glycerol and stored at −80 °C. Uniformly
15N- and/or 13C-labeled protein samples were prepared from this stock
by growing the cells in minimal medium containing 15NH4Cl and/or
13C-glucose as the only nitrogen or carbon source. The protein synthesis
was induced by addition of 0.5 mM isopropyl-1-thio-D-galactopyrano-
side (IPTG) at an OD600 of 0.8 and cells were harvested after 14 h of
induction at 19 °C. Cells were resuspended in purification buffer (110
mM potassium acetate, 20 mM HEPES [4-(2-hydroxyethyl)-1-piper-
azineethanesulfonic acid], pH 8.0, 2 mM MgCl2, 2 mM β-mercap-
toethanol (BME), 5% (v/v) glycerol and 20 mM imidazole) and ultra-
sonicated for lysis. The solution was applied to a gravity Ni-NTA
agarose (QIAGEN) column following the manufacturer's instructions.
After washing with purification buffer including 20 mM imidazole, the
protein was eluted by using purification buffer including 200 mM
imidazole and further purified by gel chromatography on an ÄKTA pure
system equipped with a HiLoad 16/600 Superdex 75 pg column (GE
Healthcare) running with purification buffer. The fractions containing
the protein were pooled, incubated with 0.2 mg TEV protease overnight
at 4 °C. On the following day, the protein solution was applied to the Ni-
NTA agarose column again to remove the cleaved tag, remaining un-
digested protein and the His6-tagged TEV protease. The eluate was then
buffer exchanged into purification buffer where BME was substituted
with 1 mM DTT using dialysis. The protein solution was aliquoted,
frozen in liquid nitrogen and stored at −80 °C. Solution NMR spectro-
scopy showed that no differences were observed after the freezing and
thawing of the samples.
2.7. Solution NMR spectroscopy
The protein stock was freshly buffer exchanged into NMR buffer (4
mM HEPES, 5 mM EDTA, pH 7.5) before measurement. Samples for
protein characterization contained 1 mM DTT (dithiothreitol) whereas
samples for redox-experiments did not. The protein concentration was
0.15 mM and contained 7% (v/v) 2H2O for the lock signal. Solution
1H15N HSQC NMR spectra were measured on an Avance III 600 Bruker
NMR spectrometer equipped with a cryogenic triple resonance probe
with gradients in the z-direction. The recycle delay of the redox ex-
periments performed was set to 1 s with a spectral window of 11/34
ppm in 1H/15N dimensions, 2048 points in the direct 1H dimension, 128
complex data points in the indirect 15N dimension, and with 8 or 16
scans per increment. Spectra were processed with the NMRPipe
package [15] and analyzed by CcpNmr Analysis [16].
For determination of the S-glutathionylation redox potential, the
concentration of GSSG in the sample buffer was gradually increased
(0.2; 1.0; 2.3; 3.3; 3.9; 5.9; 7.8; 8.8; 9.8; 11.7 mM) by titrating from a
65 mM pH corrected stock solution while the concentration of the re-
duced form of GSH was kept constant at 4 mM. At each concentration
point, a 1H15N HSQC NMR spectrum was recorded immediately after
addition of the oxidation agent. For assignment of the S-GSHylated
protein, HNCA and CBCACONH spectra were acquired. Determination
of the redox potential was performed following the protocol of Piotukh
et al. [17]. In summary, peak intensities of well isolated peaks (N71,
C72, D74, T79) of the oxidized form were normalized to a non-affected
asparagine side chain resonance and plotted against the redox potential
of the buffer. This potential was determined from the standard half-cell
potential of the glutathione redox couple (−240 mV at pH 7.0, 25 °C)
















where A1 and A2 are the initial and final plateaus of the function, dx is
the slope and x0 refers to the desired parameter of the redox potential.
For oxidized samples of p16INK4, a final concentration of 50 mM
hydrogen peroxide (H2O2, from a 30% solution diluted with NMR
buffer) or 100 μM diamide (from a freshly prepared 10 mM stock so-
lution in H2O) was added to the 15N-labeled protein solution. 1H15N
HSQC NMR spectra were acquired after the addition of the oxidizing
agent in subsequent manner. After 10 h, no spectral changes were ob-
served for WT protein anymore and the sample was applied to a size
exclusion column (HiLoad 10/300 Superdex 75 pg column, GE
Healthcare) and the aggregated fraction was pooled. The protein was
applied to SDS gel electrophoresis in the presence and absence of BME.
2.8. CD spectroscopy
Far-UV CD experiments were recorded on a J-715 spectro-
polarimeter (Jasco, Tokyo, Japan). Spectra were acquired at room
temperature with a response time of 1 s and a step resolution of 0.3 nm.
Five scans were averaged and the signal was background corrected by
subtraction of the buffer signal. The CD spectra were obtained from a 1
μM p16INK4A sample before and after oxidation with 200 μM hydrogen
peroxide for 8 h at room temperature and data were converted to molar
ellipticity. Samples were freshly prepared and transferred into a 10 mM
sodium phosphate buffer at pH 7.4 in the absence of reducing agents.
2.9. Small-angle X-ray scattering measurements
SAXS data was recorded on an in-house SAXS instrument (SAXSess
mc2, Anton Paar, Graz, Austria) equipped with a Kratky camera, a
sealed X-ray tube and a two-dimensional Princeton Instruments
PI•SCX:4300 (Roper Scientific) CCD camera. Measurements were per-
formed with 90 min exposure time (540 frames of 10 s each) of three
concentrations of 2.5 mg/ml, 1.25 mg/ml and 0.625 mg/ml in NMR
buffer. The sample of reduced p16INK4A was measured immediately
after purification and buffer exchange. The oxidized sample of p16INK4A
was treated overnight with 50m MH2O2 at room temperature. Next
day, the sample was applied to size exclusion chromatography and the
peak from 9 to 10 ml elution volume was pooled (see Figs. S6 and B)
and concentrated. Individual frames of the 90 min exposure were
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compared and no radiation damage was observed. A range of mo-
mentum transfer of 0.012 < s < 0.63 Å−1 was covered (s= 4π sin
(θ)/λ, where 2θ is the scattering angle and λ=1.5 Å is the X-ray
wavelength). SAXS data were analyzed with the package ATSAS version
2.8.1 [19]. Desmearing of the oxidized sample could not be performed
because the scattering curve showed strong aggregation.
2.10. Thioflavin-T fluorescence assay
Samples of p16INK4A (20 μM) were prepared in buffer (4 mM
HEPES, pH 7.5) with 20 μM ThT. Three replicates were measured for
each sample. Samples were subjected to 1 mm orbital shaking for 2 min
of every 5 min, in a 96-well, half-area, fluorescence plate (Corning) and
measurements were taken every 5 min. Samples were excited at 440 nm
and fluorescence emission was measured at 480 nm. Measurements
were made using a Tecan GENios microplate reader.
2.11. Negative-stain transmission electron microscopy
Protein samples were prepared by incubation of p16INK4A samples
with or without oxidizing agents for 6–24 h at RT. Copper grids with
300 meshes coated with formvar/carbon film (Electron Microscopy
Sciences, Hatfield, USA) were glow-discharged in argon atmosphere for
30 s at 3 mA. Grids were floated on a 5 μl drop of a 50 μM protein
sample and incubated for 60 s. Grids were washed once with water, and
then floated on 5 μl of uranyl acetate solution (2% w/v) for 30 s.
Micrographs were taken on either a JEOL JEM 100CX transmission
electron microscope or a JEOL JEM 1400 Plus transmission electron
microscope (JEOL, Tokyo, Japan).
2.12. Prediction of aggregation-prone regions
Four different aggregation prediction programs, TANGO [20],
PASTA [21], Zyggregator [6] and Aggrescan [22] were used to identify
putative regions responsible for the beta-aggregation of p16INK4A using
the default settings.
2.13. Congo-red absorbance
Absorbance spectra were measured on samples of p16INK4A (20 μM)
with Congo red (20 μM) in buffer (4 mM HEPES, pH 7.5). Spectra were
recorded from 400 to 650 nm, with a resolution of 2 nm, on a Tecan
Infinite 200Pro microplate reader in a 96-well plate (Corning).
2.14. Fourier-transform infrared spectroscopy
p16INK4A (80 μM) samples were treated with 50 mMH2O2 overnight
in buffer (4 mM HEPES pH 7.5), then dialysed against water overnight.
Spectra were recorded on a JASCO FT/IR-4100 FT-IR spectrometer with
attenuated total reflectance (ATR) attachment. The samples were
measured with 128 scans at a resolution of 2 cm−1 at room tempera-
ture.
2.15. Solid-state NMR spectroscopy
10 mg (150 μM) of 13C–15N labeled p16INK4A fibrils were prepared
in buffer (4 mM HEPES pH 7.5) by addition of 50 m MH2O2 and in-
cubation at 37 °C overnight. The sample was packed into a 3.2 mm MAS
rotor by ultracentrifugation. Spectra were recorded on a Bruker Avance
III 750 MHz spectrometer (Bruker BioSpin) equipped with a 3.2 mm
triple-resonance MAS probe. A proton-driven spin diffusion (PDSD)
spectrum [23] was recorded at 16.5 kHz MAS, with 50 ms mixing time,
at a set temperature of 273 K, with 352 scans and 22 ms and 8 ms
acquisition time in the direct and indirect dimensions, respectively.
Experiments were acquired using Topspin 3.2 (Bruker Biospin) and
analyzed using CCPN Analysis 2 [16] The secondary chemical shift was
calculated as [δ(Cαobserved) – δ(Cαrandom coil)] – [δ(Cβobserved) – δ
(Cβrandom coil)] with random coil chemical shifts taken from Ref. [24].
2.16. Sample preparation for mass spectrometry
HEK293T cells were transfected with FLAG-p16INK4A or FLAG-
p16INK4A C72A. After two days, half of the dishes (3 full 15 cm dishes
per sample) were treated for 10 min with diamide (250 μM) (Sigma
Aldrich) and subsequently harvested for immunoprecipitation with
FLAG beads as described before. After washing 2x with 1 M salt buffer
and 3x with PBS to remove all soap, proteins were eluted from the
beads by two times 5min incubation with 75 μl 0.1 M glycine pH 2.
The protein containing supernatant was transferred to a new tube and
incubated for 20 min with 10 mM DTT and 2 M Urea (dissolved in 100
mM Tris pH 7.5), followed by 10min incubation with iodoacetamide
(50 mM). To digest the proteins, 0.25 μg trypsin (Promega) was added
per sample and samples were incubated ON at 25 °C. The next day
C18‐stagetips were used for filtering and loading of the protein digest.
2.17. Mass spectrometry and data analysis
The mass spectrometry was performed as previously described [11].
For the analysis Maxquant software version 1.5.1.0 [25] was used.
During the analysis, oxidation of methionine, alkylation of cysteines
with iodoacetamide were set as variable modification. Proteins were
identified by the IPI human V3.68 database and the relative amounts of
protein in the separate experiments, the Intensity Based Absolute
Quantification (IBAQ) [26], as well as the label free quantification [27]
were calculated.
Further analysis was done using R version 3.4.0. The used code and
description is currently being uploaded to GitHub. Proteins identified
with two or more unique peptides were filtered for reverse hits, decoy
hits and standard contaminants and samples that show aberrant clus-
tering or low protein count were excluded. Subsequently the IBAQ data
was Log2 transformed and normalized for IP efficiency. For p-value
calculations, left-censored missing data was first imputed using a sto-
chastic minimal value approach. Imputation was performed by random
draws from a Gaussian distribution centered in the 10−4 quantile of the
known data with a standard deviation that is same as the observed
values [28] A standard t-test was performed on the imputed data and p-
values were adjusted for multiple testing using the Benjamini-Hochberg
correction.
2.18. Mass spectrometry of GS-p16INK4A
The intact mass of p16INK4A before and after oxidation by GSSG was
obtained from LC-MS analysis, that was performed on recombinantly
expressed protein (see protein expression and purification section). The
sample was desalted using 10 kDa Amicon Ultra-0.5 centrifugal filter
devices prior to measurement. 150 pmol of protein were injected into
an Agilent 1200 system (Vienna, Austria) coupled to an LTQ-FT mass
spectrometer (Thermo Fisher Scientific, Waltham, MA, USA).
Separation was carried out on a monolithic PepSwift® column (500
μm×5 cm Monolithic PS – DVB) at a flow rate of 20 μl/min using the
following gradient, where solvent A is 0.05% trifluoroacetic acid in
water and solvent B is 0.05% trifluoroacetic acid in acetonitrile: 0–5
min: 10% B; 5–55 min: 10–100% B; 55–65 min: 100% B, 65–80 min:
10% B. The sample was ionized in the electrospray source and analyzed
using FT-MS operated in positive ion mode applying full scan MS (m/z
300 to 2000) with a resolution of 400,000. Acquired data were pro-
cessed with the software Protein Deconvolution 2.0 SP2 (Thermo Fisher
Scientific) using a S/N threshold of 5 and a relative abundance
threshold of 20%.
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2.19. Flow cytometry
Cell cycle analysis was performed using a combination of the FUCCI
[13] system and DNA content staining. COLO-829 cells expressing the
FUCCI constructs as well as pINDUCER20-p16INK4A or p16INK4A-C72A
were seeded and treated with doxycycline and LEE-011 for the in-
dicated times and samples. Nocodazole was added 16 h before harvest
to capture cycling cells in mitosis to distinguish transient G1 from G1/
G0 arrested cells. Cell culture medium was collected and cells were
washed in PBS before trypsinization. Cells were fixed for 10 min at
room temperature with 2% formalin in PBS. After 2 washes with PBS,
cells were permeabilized with 70% ethanol for 30 min. Cells were re-
suspended in PBS with 0.1% BSA with DAPI and RNAse to stain the
DNA. mKO2-hCtd1(30/120), mAG-hGeminin(1/110) and DAPI were
measured using a BD FACSCelesta Flow Cytometer (BD Bioscience).
2.20. Evolutionary analysis
Amino acid sequences of vertebrate orthologues of human p16INK4A
and p15INK4B were downloaded from the ENSEMBL database [29].
Alignment and visualization of conservation was performed using Jal-
View 2.10.1 software [30], with the Clustal plugin with default settings.
3. Results
3.1. p16INK4A is oxidized to form disulfide dependent homodimers in human
cells
To test whether p16INK4A forms disulfide-dependent complexes
under oxidizing conditions, immunoprecipitation followed by non-re-
ducing SDS-PAGE was performed. Oxidation was induced using a
concentration series of either hydrogen peroxide or the thiol-specific
oxidant diamide (tetramethylazodicarboxamide) that ranged from
subtoxic (5 μM) to mildly toxic (250 μM) in HEK293T cells. FLAG-
p16INK4A readily formed intermolecular disulfide-dependent complexes
(Fig. 1A), as judged by the large mobility shift under non-reducing
conditions, that was abolished when the samples were reduced prior to
SDS-PAGE (last lanes). Note that only the FLAG-p16INK4A disulfide-de-
pendent dimer band is observed and that its intensity increases upon
exposure to increasing oxidant concentration. We did not observe a
“smear”, which would occur if p16INK4A were to undergo random,
nonspecific crosslinking to proteins. We then created p16INK4A mutants
in which the only cysteine was replaced by alanine (C72A) or serine
(C72S). We opted to use p16INK4A-C72A for our further experiments in
human cells in order to circumvent the potential effects of the in-
troduction of a novel phosphorylation site in the C72S mutant. The
C72A mutant is still functional as a cell-cycle inhibitor and hence the
mutation does not grossly affect protein function per se (Fig. S1). To
explore whether the observed intermolecular disulfide-dependent
complexes are FLAG-p16INK4A homodimers, Co-IP experiments were
performed using combinations of wild-type (WT) p16INK4A and C72A
with short (FLAG) and long (mCherry) N-terminal tags. Under non-re-
ducing conditions, bands could be observed corresponding to disulfide-
dependent dimers of FLAG-p16INK4A-S-S-FLAG-p16INK4A and of
mCherry-p16INK4A-S-S-FLAG-p16INK4A (Fig. S2A) after FLAG pull down.
Furthermore, diagonal electrophoresis showed that after reduction (2nd
dimension) FLAG-p16INK4A drops out of the diagonal as a single dot,
whereas a heterodimer would have revealed a second Simply Blue
stained protein with similar intensity dropping out of the diagonal (Fig.
S2B). To test the dynamics of the intermolecular disulfide-dependent
dimerization of p16INK4A, a time course of oxidant treatment was per-
formed, using p16INK4A-C72A as a control. The oxidation of p16INK4A
was rapid, peaked after 10 min, was fully dependent on the only cy-
steine and was resolved upon boiling in reducing sample buffer
(Fig. 1B).
Concomitantly with its oxidation, p16INK4A protein abundance
increased, and this was again dependent on its single cysteine residue.
Protein levels already increased after a few minutes of diamide treat-
ment, excluding a role for gene transcription but suggestive of a role for
decreased protein breakdown. The accumulation is best observed using
reducing SDS-PAGE because all p16INK4A then migrates in a single band
(Fig. 1B and C). The increased p16INK4A protein levels rapidly returned
to basal upon diamide wash-out with fresh media (Fig. 1C). Endogenous
p16INK4A levels follow the same trend as FLAG-p16INK4A indicating that
endogenous p16INK4A is also regulated through cysteine oxidation.
Taken together, both the increase in p16INK4A levels as well as the
oxidation are dependent on C72.
3.2. C72 of p16INK4A is readily oxidized in vitro
To study the reactivity of the p16INK4A cysteine residue directly, we
expressed and purified the isotope-labeled recombinant protein and
confirmed its correct folding by solution nuclear magnetic resonance
(NMR) spectroscopy. Upon treatment of the purified protein with oxi-
dized glutathione (GSSG), we observed chemical shift changes that
occurred most strongly in proximity to the cysteine residue of p16INK4A
(Fig. 2A and B, Fig. S3). These changes were reversed by addition of the
reducing agent DTT, confirming the involvement of reversible cysteine
oxidation. Mass spectrometric analysis of the intact protein showed that
p16INK4A was S-glutathionylated (S-GSHylated) after treatment with
GSSG (Fig. S4). S-GSHylation of the protein does not change its
monomeric state or overall fold, as indicated by identical peak line
shapes and unchanged elution times in size exclusion chromatography.
By titrating the reduced p16INK4A sample with increasing GSSG in a
GSH/GSSG redox buffer we determined the redox potential of C72
using the Nernst equation [17] to be −198.3± 1.7 mV (Fig. 2C).
To study the structural role of the cysteine residue, we used the
p16INK4A-C72S mutant, which is the most structurally conservative
mutation, differing only by replacement of the sulfhydryl group with a
hydroxyl group. This mutant showed monomeric behavior during
purification and largely identical chemical shifts as compared to the
wild-type protein (Fig. S5), indicating that the mutation does not affect
p16INK4A protein structure per se. Addition of GSSG to this mutant did
not show any indications of interaction or covalent modification. Col-
lectively, these experiments indicate that the p16INK4A C72 can be di-
rectly oxidized in vitro at physiologically occurring redox states.
3.3. Disulfide-dependent homo-dimerization of p16INK4A triggers
aggregation
The use of GSSG as an oxidant resulted in p16INK4A S-GSHylation in
vitro, whereas experiments in human cells showed S–S-linked homo-
dimerization (Fig. 1) upon treatment with diamide or H2O2, even
though both these agents lead to increased GSSG in cells. We therefore
assessed whether H2O2 and diamide can directly oxidize p16INK4A in
vitro. SDS-PAGE analysis revealed that disulfide-linked protein homo-
dimers are also formed in vitro, similar to the pattern observed in the
experiments in human cells (Fig. S6A). Comparison of size exclusion
chromatography traces of reduced and oxidized samples show that
oxidation of p16INK4A causes a shift to high molecular mass, with the
oxidized sample eluting in the void volume of the column (Fig. S6B). In
contrast to oxidation by GSSG, the addition of either H2O2 (Fig. 3A) or
diamide (Figs. S6C and S6D) led to strong NMR chemical shift changes
that indicated protein unfolding and aggregation. This indicates the
formation of a multimeric species and the absence of monomeric
p16INK4A. Characterization of reduced and oxidized WT p16INK4A by
Circular Dichroism (CD) spectroscopy revealed a transition to a less
structured species, with some alpha-helical characteristics remaining
(Fig. S7A). Small-angle X-ray scattering (SAXS) on the oxidized samples
indicates that the aggregates are larger than the detection limit of about
400 nm diameter (Fig. S7B). S-Glutathionylation of p16INK4A C72 would
abolish its reactivity towards diamide or H2O2. To exclude that the
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Fig. 1. p16INK4A forms intermolecular disulfides upon exposure to oxidants.
(A) Analysis of Immuno-precipitated FLAG-p16INK4A by non-reducing SDS-PAGE and Western Blot shows that part of the FLAG-p16INK4A migrates at about double the
molecular weight upon 5min treatment with low amounts of the thiol-specific oxidant diamide (left panel) or H2O2 (right panel). Reduction (R) prior to SDS-PAGE
abolishes the shift in molecular weight, indicating that it is indeed due to an intermolecular disulfide (see also Figs. S2A and S2B for confirmation that the high
molecular weight form of p16INK4A is an S–S-dependent homodimer).
(B) S–S-dependent p16INK4A homodimerization upon 200 μM diamide (left) or 200 μM H2O2 (right) occurs rapidly, coincides with accumulation of p16INK4A protein
levels and oxidation as well as accumulation are fully dependent on C72.
(C) Endogenous p16INK4A and over-expressed FLAG-p16INK4A accumulate in response to 200 μM diamide with similar kinetics. Note that p16INK4AC72A does not
accumulate whereas endogenous p16INK4A does, suggesting that endogenous p16INK4A levels are also regulated by Cys-oxidation. (IP: immunoprecipitation, WB:
Western Blot). All Western blots shown in Fig. 1 are typical results of several repeats (N≥ 3 for all experiments).
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observed aggregation of p16INK4A stems from modifications other than
C72, we also performed solution NMR spectroscopy on the S-glu-
tathionylated p16INK4A (GS-p16INK4A), as well as on the p16INK4A-C72A
mutant, treated with diamide or H2O2. No chemical shift changes were
observed and the monomeric, S-glutathionylated protein sample as well
as the p16INK4A-C72A mutant were stable in presence of oxidizing
agents (Fig. S8). Together, these experiments indicate the formation of
an aggregated p16INK4A species upon intermolecular disulfide bond
formation in vitro.
3.4. Disulfide-linked homodimers of p16INK4A form β-amyloid fibrils
Based on the indications of aggregation, transmission electron
microscopy (EM) was employed to study the nature of the p16INK4A
aggregates that formed upon oxidation. Interestingly, we found that the
oxidized p16INK4A samples produced fibrillar structures (Fig. 3B). One
prominent group of fibrillar proteins are amyloid fibrils, which are
characterized by a cross-β sheet core structure, meaning that β-strands
run perpendicular to the fibril long axis [31,32]. To determine if
p16INK4A fibrils are amyloid, we used the amyloid-specific dyes Thio-
flavin T (ThT) and Congo Red [33–35]. ThT assays showed an increase
in fluorescence, which is characteristic for amyloids, when bound to
oxidized p16INK4A (Fig. 3C), while Congo Red absorbance measure-
ments showed the red shift and increased absorbance characteristic of
amyloid binding (Fig. 3D). Fourier-transform infrared spectroscopy can
distinguish cross β-sheets found in amyloid fibrils from β-sheets found
Fig. 2. In vitro oxidation of p16INK4A
(A) 1H15N HSQC solution NMR spectrum of
recombinant p16INK4A in the reduced state
(blue) and after S-glutathionylation (ma-
genta). Amino acids with large chemical
shift changes are labeled.
(B) Cartoon representation of the p16INK4A
structure. A color gradient from white (un-
affected) to red (strongly affected) shows
the influence of S-glutathionylation on the
chemical shift.
(C) The redox potential of C72 is
198.3 ± 1.7 mV, as determined from in-
tensity changes of four well-separated
amino acids by titration of the reduced
protein with oxidized glutathione. (For in-
terpretation of the references to color in this
figure legend, the reader is referred to the
Web version of this article.)
Fig. 3. p16INK4A forms amyloid fibrils under oxidizing conditions
(A) 1H,15N HSQC solution NMR spectra of recombinant p16INK4A before (blue) and after (orange) oxidation with 50 mM H2O2 for 10 h at room temperature
(orange). The collapse of the peaks to the center of the spectrum suggests formation of unstructured or aggregated protein.
(B) Negative-stained transmission electron micrographs of diamide-treated p16INK4A showing the presence of amyloid fibrils. Right panel is at higher magnification,
arrows highlight the twisted morphology which is typical of amyloid fibrils.
(C) Fibril formation of p16INK4A monitored by thioflavin-T fluorescence measurement. Error bars represent standard deviation from four measurements.
(D) Fibril formation of p16INK4A monitored by Congo red absorption. The absorption maximum shifts when bound to oxidized p16INK4A, indicating the presence of
amyloid fibrils.
(E) Amide I region of the attenuated-total-reflectance Fourier-transform infrared spectra of p16INK4A monomer and fibrils. Peak maxima indicate that the structure
contains primarily α-helix for monomers and cross-β sheet for fibrils. (For interpretation of the references to color in this figure legend, the reader is referred to the
Web version of this article.)
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in globular monomeric proteins [36,37]; in line with the dye-binding
data, p16INK4A fibrils had a maximum at 1620 cm−1, which falls within
the typical amyloid β-sheet region, confirming the amyloid structure of
the fibrils (Fig. 3E). We performed a computational analysis using four
fibril prediction algorithms [20–22,38] and all suggested a high pro-
pensity for β-amyloid formation in the region from residue no. 91–99
(Fig. S9A).
Additionally, we recorded solid state NMR spectra on a uniformly
13C-labeled p16INK4A sample to confirm the secondary structure of the
aggregated state. Samples were prepared using the same conditions that
were used for other experiments including electron microscopy, to
ensure that results are comparable between experiments. In 13C–13C
correlation spectra, only amino acid residues within a structured core
are visible (Fig. S9). The spectrum shows relatively few peaks compared
to the 156 residues of full-length p16INK4A, suggesting that only specific
parts of the sequence form the structural core of the amyloid fibrils.
This is also indicated by the absence of certain residue types from the
spectrum, for example isoleucine (Fig. S9B). Many of the peaks could be
assigned to their amino-acid type due to their distinctive Cα and Cβ
peak positions, which allowed for determination of the secondary
structure. Nearly all assigned peaks have peak positions that are char-
acteristic for β-sheet or random coil (Fig. S9C), confirming that
p16INK4A aggregates have a β-sheet core and are therefore amyloid.
These findings emphasize the dramatic structural rearrangement from
the monomeric eight-α-helical bundle that is devoid of β-sheets.
3.5. Intermolecular p16INK4A disulfide bond formation is essential for
amyloid fibril assembly
We further investigated the role of oxidation of the cysteine residue
in fibril formation by comparing the p16INK4A WT protein to p16INK4A-
C72S. Electron microscopy revealed that upon treatment with as little
as 200 μM H2O2 or diamide, WT samples formed large fibrillar struc-
tures (Fig. 4A, top panels). There was no discernible difference between
the morphology of fibrils formed with diamide or H2O2 treatment, or
when higher concentrations of oxidizing agent were used. p16INK4A-
C72S samples displayed a very different morphology, instead forming
unordered, amorphous aggregates, as well as a small amount of short
fibrillar species (Fig. 4A, middle panels).
Glutathionylated-p16INK4A (GS-p16INK4A) samples were also ana-
lyzed by electron microscopy, and were found to form large, granular
aggregates without any fibrils upon treatment with either H2O2 or
diamide (Fig. 4A, bottom panels). Although aggregates are seen by
electron microscopy, the solution NMR spectra of GS-p16INK4A indicate
the sample is largely soluble and monomeric (Fig S8A, S8B), suggesting
that the aggregates seen by electron microscopy constitute only a small
proportion of the total GS-p16INK4A protein.
We next investigated the influence of intermolecular disulfide bond
formation on the kinetics of fibril formation, by measuring the time-
and oxidation-dependence of p16INK4A WT, p16INK4A C72S and GS-
p16INK4A variants using the ThT assay (Fig. 4B). Upon treatment of WT
p16INK4A with oxidizing agents, the sample fluorescence rapidly in-
creased as ThT-positive fibrils were formed, with maximum signal
being achieved within 2 h upon 200 μM diamide treatment (Fig. 4B,
top) and more than 16 h for 200 μMH2O2 treatment (Fig. 4B, middle),
while no fibrils were formed in the absence of oxidizing agents (Fig. 4B,
bottom). The C72S mutant displayed only a very slight increase in
fluorescence over time, and this was not affected by the presence or
absence of oxidizing agents. GS-p16INK4A did not form ThT-positive
aggregates under any condition. The amyloids formed in vitro were
reversible: boiling in non-reducing sample buffer for 5min prior to SDS-
PAGE resulted mainly in detection of the S–S-dependent dimers (Fig.
S10). The EM and ThT-kinetics data emphasize that the amorphous
aggregates observed by EM for the p16INK4A-C72S and GS-p16INK4A are
not amyloid, both by morphology and by dye-binding properties.
Therefore, we conclude that the intermolecular disulfide bond forma-
tion of p16INK4A through C72 is critical for the formation of p16INKA
amyloid fibrils.
Fig. 4. C72 is important for fibrillar
morphology and ThT binding.
(A) Negative-stain transmission electron
micrographs of p16INK4A treated with 200
μM hydrogen peroxide (left) and 200 μM
diamide (right). Top: WT p16INK4A. Middle:
p16INK4A-C72S. Bottom: GS-p16INKA.
(B) Thioflavin-T fluorescence kinetics assay
of p16INK4A samples (WT, C72S and GS)
with 200 μM diamide addition (top) 200
μM H2O2 addition (middle) and without
oxidizing agents (bottom). Three replicates
were measured per sample and each are
separately plotted.
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Fig. 5. p16INK4A aggregates in live cells in response to oxidation.
(A) Set up for the Filter Trap assay for the detection of aggregates in cell lysates.
(B) Results for the Filter Trap assay. Note that the majority of p16INK4A in the pellet is in the form of S-S-linked homodimers after lysis. p16INK4A, but not
p16INK4AC72A, was trapped on the filter membrane upon treatment with 200 μM diamide and trapping was prevented by pretreatment with DTT. Equal amounts of
p16INK4A and p16INK4AC72A were used as input for the filter trap assay. Note that the input for the Filter Trap assay runs mainly as a S–S-dependent dimer after
boiling in non-reducing SDS-PAGE sample buffer. R: reducing, NR: non-reducing.
(C) Aggregates of p16INK4A peak around 30 min and are then cleared over time.
(D) Endogenous p16INK4A also forms S–S-linked dimers that (partially) form aggregates in the insoluble pellet fraction. Note that also mixed S–S-linked dimers of
endogenous and overexpressed p16INK4A can be observed in lanes where FLAG-p16INK4A was transfected. n.i.: IP with non-immune serum as a control. p16(r):
rabbit anti-p16INK4A, p16(m): mouse anti-p16INK4A, e.v.: empty vector, Red: reducing, Non-Red: non-reducing. All experiments were performed at least 3 times.
Representative experiments are shown.
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3.6. p16INK4A cysteine oxidation triggers its aggregation in cultured cells
Having shown that p16INK4A forms amyloid fibrils upon oxidation in
vitro, we investigated to what extent this behavior was conserved in
cultured human cells. HEK293T cells expressing FLAG-tagged p16INK4A
WT and p16INK4A C72A mutant were exposed to diamide and processed
for a filter trap assay: an assay that is commonly used to detect amyloids
in cell extracts (Scheme top of Fig. 5A). Exposure to diamide prior to
lysis rapidly led to accumulation of the p16INK4A homodimer in the
solubilized pellet fraction and subsequent trapping of p16INK4A on the
filter membrane, and both were dependent on C72. Reduction of the
protein lysates with DTT prior to washing abolished trapping, sug-
gesting that the aggregation was reversible (Fig. 5B). Clearance of
p16INK4A aggregates was observed over time after diamide treatment.
After 120 min the aggregates were largely resolved (Fig. 5C), re-
miniscent of turnover of the disulfide-linked homodimer in Fig. 1C.
We also studied whether oxidation induced the aggregation of en-
dogenous p16INK4A, for which the expression levels are generally lower
than those of transfected FLAG-p16INK4A. We found that endogenous
p16INK4A also forms disulfide-linked dimers upon oxidation and that
part of these accumulate in the insoluble pellet fraction (Fig. 5D). Si-
milar amounts of endogenous p16INK4A are found in the solubilized
pellet fraction in the presence and absence of transfected FLAG-
p16INK4A, suggesting that endogenous p16INK4A levels are sufficient to
form homodimers and aggregates (see Reducing IP panels). The phase-
transition from monomeric to the amyloid form of p16INK4A would
likely change its biochemical properties and protein-protein interac-
tions. To test this, the interactomes of immunoprecipitated FLAG-
p16INK4A and FLAG-p16INK4AC72A were investigated and compared by
label-free quantitative mass spectrometry. Under basal conditions the
interactomes were largely identical, but this changed dramatically upon
diamide treatment (Fig. S11). Diamide-treated WT p16INK4A indeed
showed a large number of binding partners not identified in diamide-
treated p16INK4A-C72A pull-downs. The interaction with CDK4 and
CDK6 was not affected by diamide treatment or the C72A mutation.
Proteins that form amyloids are known to bind to chaperones and in-
deed several Heat Shock Proteins were found to interact with WT
p16INK4A upon diamide treatment, again indicative of aggregate for-
mation.
3.7. p16INK4A cysteine oxidation restores CDK4/6 kinase activity
We then investigated how the p16INK4A function as a CDK4/6 in-
hibitor would be affected by amyloid formation. CDK4/6 was co-im-
munoprecipitated with FLAG-tagged p16INK4A, and in vitro kinase assays
were performed using a GST-tagged Rb fragment as a substrate (Scheme
Fig. 6A). These experiments revealed that oxidation of WT p16INK4A or
p16INK4A-C72S did not greatly affect the binding to CDK4/6 (Fig. 6A),
which agrees with our observations in the MS experiments (Fig. S11).
The in vitro kinase assay showed that p16INK4A-associated CDK4/6 was,
as expected, inactive under basal conditions. CDK4/6 activity towards
the GST-Rb fragment was regained when cells were exposed to diamide
prior to lysis, despite the increased amount of p16INK4A that was pulled
down. The reactivation was strictly dependent on p16INK4A C72. Taken
together, these observations suggest that the amyloid form of p16INK4A
still interacts with CDK4/6 but in a manner that does not lead to kinase
inhibition.
To test how p16INK4A oxidation and aggregation impacts on the total
CDK4/6 activity we performed qPCR analysis on the expression of
Cyclin E2 (CCNE2), which is a transcriptional target of E2F1 and hence
should be upregulated by active CDK4/6. CCNE2 (Fig. 6B, lower panel)
was strongly repressed upon the doxycycline-induced p16INK4A or
p16INK4A-C72A expression (Fig. 6B, top panel) in otherwise p16INK4A
deficient COLO829 melanoma cells. CCNE2 transcription was partially
restored upon diamide treatment, but not in the cells expressing the
p16INK4A-C72A redox-insensitive variant. The induction of CCNE2 by
diamide in the absence of doxycycline in the p16INK4A WT cell line is
likely due to the fact that the inducible system is somewhat leaky. Al-
though we did find evidence that CDK4/6 is indeed reactivated upon
oxidation of p16INK4A, and that this partially relieves E2F1 repression,
we did not find evidence of perturbation of the S-phase checkpoint in
cell-cycle analysis experiments using flow cytometry and video time-
lapse microscopy (data not shown). This might be explained by the
notion that substantial amounts of monomeric p16INK4A persist under
conditions where we find aggregated p16INK4A in the insoluble pellet
fraction of our lysates. The observed reactivation of CDK4/6 might
therefore not be strong enough for full re-entry of the cell cycle under
the tested conditions, but we cannot exclude that this might occur in
other situations. Furthermore, treatment with oxidizing agents also
affects the cell cycle through several other pathways, possibly ob-
scuring p16INK4A oxidation dependent effects.
3.8. Evolutionary analysis of the redox sensitive cysteine in p16INK4A
Aggregation and inactivation of a tumor suppressor protein may
seem a maladaptive response to oxidizing conditions, although we
cannot exclude that it may support another currently unknown biolo-
gical function. Conservation of evolutionarily-acquired cysteines at the
surface of proteins can be indicative for a role in redox signaling,
whereas the loss of acquired cysteines may indicate the cysteine ham-
pers protein function [11,39]. We therefore investigated to what extent
p16INK4A Cys72 is conserved throughout evolution. The genes encoding
p16INK4A (CDKN2A) and p15INK4B (CDKN2B) are the product of a gene
duplication that occurred somewhere in evolution around the time that
the mammalian branch of the evolutionary tree was formed [40] (see
Fig. S12A for reference). Strikingly, Cys72 in the human protein is not
conserved in any of the protein sequences of the CDKN2 orthologues in
fish, birds, reptiles and amphibians. Yet, this cysteine is present in both
p16INK4A and p15INK4B in almost all mammalian species for which se-
quence information is available in the ENSEMBL database [29], sug-
gesting that acquisition of this cysteine occurred just before or coin-
cided with the gene duplication of the ancestral CDKN2 gene (Fig. 7A
and B). Further investigation of the protein sequences of the p16INK4A
and p15INK4B orthologues revealed that the cysteine homologous to the
human p16INK4A-Cys72 was substituted later in evolution in several
branches of mammalian species including some primates, rodentia and
perissodactyla (see Fig. 7A and B and Fig. S12B). The latter could in-
dicate that redox regulation of the acquired cysteine homologous to
human p16INK4ACys72 is not absolutely required for a p16INK4A function
and that Cys72 might be slightly deleterious and displays a weak pur-
ifying selection.
4. Discussion
Amyloid fibrils are structures that can be formed by a wide variety
of protein sequences [41]. These fibrils share common features, in-
cluding an unbranched fibrillar morphology and a cross-β sheet core
structure. Amyloids were previously thought to be largely disease-re-
lated, especially involved in neurodegenerative diseases, but there are
increasing numbers of amyloid fibrils discovered that have a physio-
logical function. Several mammalian examples have been reported in
recent years, including the melanosome protein pMeL, amyloids in-
volved in hormone storage, and the RIPK proteins, whose fibril for-
mation appears to trigger necroptotic signaling pathways [42–45]. In
this work we show that p16INK4A can form fibrils under physiological
conditions and in cell-based models, and that the formation is triggered
by oxidation of the single cysteine residue and homodimerization. We
presented evidence that p16INK4A can form aggregates that have the
typical features of amyloid fibrils, including binding of diagnostic dyes,
presence of cross-β sheet structure, and typical dimensions found in EM.
The critical dependence of a disulfide cross-linked dimer as a subunit
has not been observed so far and highlights the role of the cellular redox
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state as an important regulator of fibril formation.
The role of cysteine chemistry in amyloid formation has been dis-
cussed in detail previously [46]. Most commonly, disulfide bonds are
found to stabilize a soluble, usually monomeric, form of the protein,
preventing its un- or misfolding and aggregation. In many cases,
blocking of disulfide bond formation by mutagenesis or chemistry
generates proteins that are more prone to amyloid formation, such as
has been demonstrated for lysozyme [47], SOD1 [48,49], insulin [50]
and prion protein [51,52]. In contrast, oxidation of the single cysteine
of p16INK4A is important for the transition of the monomeric protein to
form amyloid fibrils, and modification of the cysteine by mutagenesis or
S-glutathionylation prevents its amyloid formation. Proteins in which
disulfide bonds have been postulated to be involved in stabilization of
amyloid fibrils include the prion protein and RIPK fibrils, however
disulfide bond formation itself is not required for conversion to amyloid
in either of these cases [51–53].
Several properties of p16INK4A fibrils fit with those expected for
functional amyloids, including their rapid formation (instead, disease-
related amyloids can take days to form fibrils) [54,55], and their lack of
clear polymorphism (no evidence of peak doubling in the solid-state
NMR spectrum) [56,57]. We have shown that p16INK4A fibrils can be
formed in vitro under relatively mildly oxidizing conditions at physio-
logical pH. In contrast to many other amyloid-forming proteins,
p16INK4A does not require harsh treatments, such as extreme pH, high
temperatures, high pressure or organic solvents, that are frequently
used to destabilize folded proteins in order to convert them to amyloid
fibrils in a practical time scale. One striking difference in the properties
of p16INK4A amyloid fibrils, compared to classical disease-linked amy-
loids like amyloid-β and α-synuclein, is the apparent reversibility of the
fibrillar state. Typical amyloids are highly stable and are not dis-
aggregated by SDS buffers and do not run into SDS-PAGE gels
[41,58,59]. Our results show that SDS is able to disaggregate p16INK4A
fibrils into dimers, and that reducing-agent treatment further returns
p16INK4A to a monomeric state. This was shown for both recombinantly-
produced p16INK4A amyloid in vitro, as well as p16INK4A amyloid formed
in a cellular model. Furthermore, we find that p16INK4A amyloids are
transiently formed and do not persist in the cellular environment as
judged by the filter trap assay. Clearance of the amyloids in cells could
in principle proceed through degradation or disaggregation into
monomers. There does not seem to be a clear increase of the monomeric
form upon disappearance of the aggregates, which could suggest that
the aggregates are being degraded rather than disaggregated. A recent
study showed that p16INK4A also forms aggregates upon inhibition of
autophagy [60], which is in line with this notion. The observation that
p16INK4A amyloids are reversible and can be cleared from cells poten-
tially adds to an emerging pattern of lability of amyloid fibrils that have
functional roles in the cell. For example, RIPK1/3, and the phase-se-
parating proteins FUS and hnRNPA2 are all reported to form functional
Fig. 6. Oxidation of p16INK4A impairs its
inhibitory function towards CDK4/6.
(A) In vitro CDK4/6 kinase assay on WT
p16INK4A pulldowns shows that the oxida-
tion of p16INK4A-C72 impairs its inhibitory
function. Note that oxidation or mutation of
Cys72 does not affect the amount of CDK4/
6 that is co-immunoprecipitated. (R:
Reducing, NR: Non-reducing). All Western
blots shown in Fig. 6 are typical results of
several repeats (N≥ 3 for all experiments).
(B) qPCR analysis showing the expression of
WT p16INK4AWT or p16INK4A-C72A (top) in
COLO-829 cells upon induction of expres-
sion from the respective pINDUCER20-
p16INK4A construct. CCNE2 expression
(bottom) is strongly repressed both by WT
p16INK4A and p16INK4A-C72A. Diamide
treatment relieves this repression only in
the WT p16INK4 expressing cell line. Note
that the inducible system is somewhat
leaky, which could explain induction of
CCNE2 in the p16INK4AWT cells by diamide
in the absence of doxycycline. The mean
plus SEM is displayed from n = 5 biological
replicates. *p < 0.05, **p < 0.01, pair-
wise comparison using a two-sided t-test
comparing cells carrying the inducible WT
p16INK4 or p16INK4A-C72A construct in each
condition.
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amyloid fibrils, and are apparently SDS soluble [50,53]. This may be a
hallmark for functional fibrils, which must be regulated and removed
when the function is no longer needed. In contrast, highly stable, per-
sistent aggregates may have toxic properties, such as in the case of Tau
or TDP-43 aggregates, which are pathogenically related to various
neurodegenerative diseases [61,62].
It is now generally accepted that the cellular redox environment
contributes to various signaling pathways and that H2O2 can act as a
secondary messenger molecule [9]. Cysteine residues are frequently
found to be modified in large-scale analysis of the cysteinome and
thousands of proteins are affected by redox regulation [63,64]. Redox
potentials vary widely between cell types and specific compartments,
ranging from −374 mV for the strongly reducing NADPH/NADP+
redox couple in the liver cytosol to −180 mV from the GSH/GSSG
couple in the oxidizing endoplasmic reticulum of B-cells [18]. In ad-
dition, the average redox potential varies greatly between cell cycle
stages [65]. The redox potential of −198 mV that we found for the
oxidation of C72 of p16INK4A is well within the physiological range. One
difference between in vitro and cell culture oxidation of p16INK4A is that
in vitro p16INK4A could be stably GSH-ylated whereas in cell cultures we
only observed the disulfide-bonded homodimer. This might seem sur-
prising, because there is ample GSH available in the cell and addition of
micromolar ranges of diamide will likely react to form GSSG. Therefore,
it may be unlikely that in cells diamide and H2O2 oxidize p16INK4A
directly, but rather that its oxidation is the result of a redox relay or
disulfide exchange mechanism, as has been proposed for other redox-
sensitive proteins [66]. However, we cannot exclude that transient
GSH-ylation of p16INK4A occurs in cells. Of note, tumor cells have been
frequently reported to exhibit a more oxidizing milieu [67]. This could
mean that p16INK4A would be more often in the dimerized and
aggregated state, which could contribute to reactivation of CDK4/6 in
tumors that express p16INK4A. One might argue that p16INK4A in-
activation by oxidizing conditions would be an inadequate response,
that would be lost through evolutionary pressure. Evolutionary analysis
indeed shows that the cysteine homologous to human p16INK4A-Cys72
was acquired recently: near or coinciding with the appearance of
mammals and was then substituted again multiple times in several
branches of mammalian evolution. However, this analysis would have
to be further extended to be able to reject a potential beneficial biolo-
gical role for p16INK4A amyloid formation, for instance to temporarily
reactivate CDK4/6 in cells with high p16INK4A levels. Whether and how
this indeed could also contribute to tumor progression remains to be
established. Our pull-down experiments indicate that oxidation of
p16INK4A leads to loss of its inhibitory activity towards CDK4/6 but that
oxidized p16INK4A and CDK4/6 still interact. We speculate that the
CDK4/6 interaction that we observe is of a different nature, which
could underlie loss of inhibition of CDK4/6 upon oxidation of p16INK4A.
Amyloid formation-dependent inactivation of tumor suppressor pro-
teins has been described before for p53 and also in this case amyloid
formation was reversible [68].
Taken together, the presented work shows that redox signaling can
trigger the formation of amyloid fibrils from an otherwise alpha-helical
protein. Conversion of a protein from a soluble, monomeric to an in-
soluble, β-amyloid fibrillar phase dependent on the cellular redox state
has not been reported before. This could pose a more general me-
chanism in amyloid formation, as was recently shown for redox-de-
pendent liquid-liquid phase-separation [69]. It also adds to the re-
pertoire of structural alterations known to occur in response to redox
signaling.
Fig. 7. Evolutionary analysis of p16INK4A and its paralogue p15INK4B.
(A) Conservation of Cys72 in human p16INK4A and (B) Cys74 in its paralogue p15INK4B throughout vertebrate evolution. Note that ENSEMBL [29] assigns some non-
mammalian orthologues to either p16INK4A or p15INK4B whereas gene duplication to yield these paralogues did not take place until mammalian species had branched
off [40]. Sequences are named by ENSEMBL ID [29]. The human orthologues are indicated with * and in bold. Cysteines conserved at the position homologous to
human p16INK4ACys72 are indicated on yellow background, other cysteines are in yellow text. The darker the purple shading the more conserved the amino acids.
Note that several distant branches of mammals have lost the cysteine homologous to human p16INK4ACys72. See Fig. S12 for a schematic tree of vertebrate and
mammalian evolution for reference. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)
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